Cargando…

Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer

BACKGROUND: Esophageal cancer (EC) is one of the deadliest solid malignancies, mainly consisting of esophageal squamous cell carcinoma (ESCC) and adenocarcinoma (EAC). Robust biomarkers that can improve patient risk stratification are needed to optimize cancer management. We sought to establish pote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Kui, Ma, Tianjiao, Ling, Xiaodong, Liu, Mingdong, Jiang, Xiangyu, Ma, Keru, Zhu, Jinhong, Ma, Jianqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576717/ https://www.ncbi.nlm.nih.gov/pubmed/34790797 http://dx.doi.org/10.21037/atm-21-5217

Ejemplares similares

Integrated analysis of immune infiltration in esophageal carcinoma as prognostic biomarkers
por: Yin, Hang, et al.
Publicado: (2021)

Improvement of ACK1-targeted therapy efficacy in lung adenocarcinoma using chloroquine or bafilomycin A1
por: Zhu, Jinhong, et al.
Publicado: (2023)

Development and validation of the novel subclassification of pN3 for patients with esophageal cancer
por: Ma, Keru, et al.
Publicado: (2023)

Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma
por: Cao, Kui, et al.
Publicado: (2022)

Identification and validation of an eight-lncRNA signature that predicts prognosis in patients with esophageal squamous cell carcinoma
por: Zhang, Jinfeng, et al.
Publicado: (2022)

Development of a cuproptosis-related signature for prognosis prediction in lung adenocarcinoma based on WGCNA
por: Ling, Xiaodong, et al.
Publicado: (2023)

UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Xiaoyuan, et al.
Publicado: (2021)

UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma
por: Zhu, Jinhong, et al.
Publicado: (2021)

Prognostic Value of Combination of Controlling Nutritional Status and Tumor Marker in Patients with Radical Non-Small-Cell Lung Cancer
por: Ma, Keru, et al.
Publicado: (2022)

LncRNA HAR1A Suppresses the Development of Non-Small Cell Lung Cancer by Inactivating the STAT3 Pathway
por: Ma, Jianqun, et al.
Publicado: (2022)

High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer()
por: Zhu, Jinhong, et al.
Publicado: (2016)

Comprehensive Analysis of the Immune Implication of ACK1 Gene in Non-small Cell Lung Cancer
por: Zhu, Jinhong, et al.
Publicado: (2020)

Prognostic implications of autophagy-associated gene signatures in non-small cell lung cancer
por: Liu, Yang, et al.
Publicado: (2019)

LINC00669 promotes lung adenocarcinoma growth by stimulating the Wnt/β‐catenin signaling pathway
por: Zhu, Jinhong, et al.
Publicado: (2023)

Identification of Immune Subtypes of Esophageal Adenocarcinoma to Predict Prognosis and Immunotherapy Response
por: Ling, Chen, et al.
Publicado: (2022)

An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Esophageal Adenocarcinoma
por: Yang, Chuang, et al.
Publicado: (2023)

An Immune-Related Gene Pairs Signature Predicts Prognosis and Immune Heterogeneity in Glioblastoma
por: Zhang, Nijia, et al.
Publicado: (2021)

Prognostic and Immunological Implications of FAM72A in Pan-Cancer and Functional Validations
por: Bai, Yuwen, et al.
Publicado: (2022)

A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer
por: Ren, Qianhe, et al.
Publicado: (2023)

Development of Personalized Signature Based on the Immune Landscape to Predict the Prognosis of Osteosarcoma and the Response to Immunotherapy and Targeted Therapy
por: Feng, Xiaofei, et al.
Publicado: (2022)

Establishment of Immune-related Gene Pair Signature to Predict Lung Adenocarcinoma Prognosis
por: Jiang, Xueping, et al.
Publicado: (2020)

The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
por: Lu, Hao, et al.
Publicado: (2022)

Identification of downstream signaling cascades of ACK1 and prognostic classifiers in non-small cell lung cancer
por: Zhu, Jinhong, et al.
Publicado: (2021)

A signature of 17 immune-related gene pairs predicts prognosis and immune status in HNSCC patients
por: Jiang, Pan, et al.
Publicado: (2020)

Immune‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer
por: Wang, Yejinpeng, et al.
Publicado: (2020)

A Promising Esophageal Cancer Prognostic Signature of Ferroptosis-Related LncRNA to Predict Immune Scenery and Immunotherapy Response
por: Liu, Xiaoxiao, et al.
Publicado: (2021)

Identification of an Autophagy-Related Pair Signature for Predicting Prognoses and Immune Activity in Pancreatic Adenocarcinoma
por: Zhang, Qian, et al.
Publicado: (2021)

Identification and Validation of Immune-Related Long Non-Coding RNA Signature for Predicting Immunotherapeutic Response and Prognosis in NSCLC Patients Treated With Immunotherapy
por: Ma, Jianli, et al.
Publicado: (2022)

Prognosis signature for predicting the survival and immunotherapy response in esophageal carcinoma based on cellular senescence-related genes
por: Wang, Yue, et al.
Publicado: (2023)

A robust immune-related gene pairs signature for predicting the overall survival of esophageal cancer
por: Zheng, Wei, et al.
Publicado: (2023)

A Novel Immune-Gene Pair Signature Revealing the Tumor Microenvironment Features and Immunotherapy Prognosis of Muscle-Invasive Bladder Cancer
por: Zheng, Xiaonan, et al.
Publicado: (2021)

APOBEC mutational signature predicts prognosis and immunotherapy response in nonsmoking patients with lung adenocarcinoma
por: Ma, Jianli, et al.
Publicado: (2023)

Development of an immune-related gene pairs signature for predicting clinical outcome in lung adenocarcinoma
por: Wu, Chunlei, et al.
Publicado: (2021)

29 immune-related genes pairs signature predict the prognosis of cervical cancer patients
por: Nie, Han, et al.
Publicado: (2020)

Prediction of clinical prognosis in cutaneous melanoma using an immune-related gene pair signature
por: Yang, Yu, et al.
Publicado: (2021)

An immune-related gene signature predicts prognosis of gastric cancer
por: Jiang, Bitao, et al.
Publicado: (2019)

A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma
por: Bu, Xiaoyun, et al.
Publicado: (2022)

The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma
por: Yao, Kai, et al.
Publicado: (2023)

Immune-related lncRNA pairs as novel signature to predict prognosis and immune landscape in melanoma patients
por: Li, Zhehong, et al.
Publicado: (2022)

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
por: Wu, Gujie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_baar0mbhqkis4f3jl2djhoe272